Matinas Biopharma Holdings I

On July 10, 2026, Matinas BioPharma entered into a business combination agreement with GH Power Inc., a Canadian company. Under the deal, Matinas will merge into a newly formed public company, and Matinas shareholders will receive 0.1 shares of the new company for each Matinas common share they own. Based on the agreed valuations ($24.7 million for Matinas, $250 million for GH Power), Matinas equityholders are expected to own about 9% of the combined company, while GH Power equityholders will own about 91%. Additionally, a former financial advisor to Matinas will receive $2 million in cash and $2 million in shares of the new company upon closing.